PANCREATIC CANCER NON-RESECTABLE
Clinical trials for PANCREATIC CANCER NON-RESECTABLE explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC CANCER NON-RESECTABLE trials appear
Sign up with your email to follow new studies for PANCREATIC CANCER NON-RESECTABLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New catheter targets pancreatic cancer tumors directly
Disease control Recruiting nowThis early study tests a new catheter system that delivers the chemotherapy drug Gemcitabine directly into or near pancreatic tumors. It includes 9 patients with advanced pancreatic cancer that cannot be removed by surgery. The goal is to see if this approach is safe and feasible…
Matched conditions: PANCREATIC CANCER NON-RESECTABLE
Phase: PHASE1, PHASE2 • Sponsor: Smartwise Sweden AB • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Radiation boost may help control advanced pancreatic cancer
Disease control Recruiting nowThis phase II trial tests whether adding a precise, high-dose form of radiation (SBRT) to standard maintenance chemotherapy can help people with advanced pancreatic cancer live longer. The study enrolls 24 adults whose cancer has not grown after at least four months of initial ch…
Matched conditions: PANCREATIC CANCER NON-RESECTABLE
Phase: PHASE2 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Can genes predict chemo success in pancreatic cancer?
Disease control Recruiting nowThis study looks at how the genetic makeup of pancreatic cancer affects response to a chemotherapy called FOLFIRINOX given before surgery. About 45 adults with non-metastatic pancreatic cancer will receive the chemo, then have their tumors analyzed to see if genetic subtypes (lik…
Matched conditions: PANCREATIC CANCER NON-RESECTABLE
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New blood test aims to spot pancreatic cancer before It's too late
Diagnosis Recruiting nowThis study is testing a new blood test called PANXEON that looks for tiny genetic particles (miRNAs) to detect pancreatic cancer early. Researchers will collect blood samples from 2,000 people—some with pancreatic cancer and some without—to see how accurate the test is. If it wor…
Matched conditions: PANCREATIC CANCER NON-RESECTABLE
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC
-
New trial aims to cut opioid use in pancreatic cancer with early nerve block
Symptom relief Recruiting nowThis study tests whether giving a nerve block early, rather than waiting, can better control pain in people with inoperable pancreatic cancer. The procedure uses an endoscope to inject numbing medication near nerves that carry pain signals. Researchers will compare pain scores an…
Matched conditions: PANCREATIC CANCER NON-RESECTABLE
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC